Pfizer India has announced the appointment of S Sridhar as the company’s managing director with effect from March 18 for a term of five years.
- Sridhar is a chartered accountant by profession with over 20 years of experience.
- He has served as Pfizer chief financial officer for seven years, and was appointed as ED in May 2013.
- He has also concurrently led the company’s distribution function for three years, and is at present heading Pfizer’s anti-infective, cardiovascular and ophthalmology businesses.
- Aijaz Tobaccowalla, the erstwhile Pfizer India head, was offered a new global role with US-based Pfizer Inc, last year.
- At Pfizer, Sridhar has led a number of strategic initiatives that have significantly expanded the company’s business footprint in the country.
- He is also responsible for developing the integrated company’s ‘institutional business‘ strategy.
- This resulted in a strong Pfizer product portfolio presence in major institutions across the country.
- He also led the development of the company’s multi-channel marketing strategy.
Did You Know?
- Pfizer Inc is an American global pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut.
- It is among the world’s largest pharmaceutical companies.
- Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.
- Pfizer was founded in 1849 by cousins Charles Pfizer and Charles F. Erhart in New York City as a manufacturer of fine chemicals.
- Its discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company.
